PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2026Nature2 citationsOpen Access

Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor

GYGang YeFBFan BuHTHailey Turner-Hubbard

Key Points

  • This research aims to detail the structures of Marburgvirus glycoprotein and its interaction with the NPC1 receptor to understand viral entry mechanisms.
  • Utilized cryogenic electron microscopy to determine three structural states of MBV glycoprotein.
  • Analyzed interactions between MBV glycoprotein and NPC1 receptor under different binding conditions.
  • Assessed the impact of glycan cap cleavage on receptor binding and membrane fusion dynamics.
  • MBV glycoprotein enables more effective viral entry compared to Ebola glycoprotein.
  • NPC1 binding induces significant conformational changes in MBV glycoprotein.
  • Neutralizing nanobody can mimic NPC1 binding, suggesting potential for therapeutic development.

Abstract

Marburgviruses (MBVs) cause severe haemorrhagic fever with higher fatality rates than Ebola virus (EBOV)1-4. Here we show that the MBV glycoprotein (GP) mediates viral entry more efficiently than EBOV GP. Using cryo-EM, we determined structures of MBV GP in three states: (1) unbound; (2) bound to its endosomal receptor NPC1; and (3) complexed with a neutralizing nanobody. The glycan cap shields the receptor-binding site from NPC1 but only partially from the nanobody, enabling limited immune evasion. After glycan cap cleavage, NPC1 binds to MBV GP in a distinct orientation compared with EBOV GP, providing an additional anchor and enhancing receptor affinity. NPC1 engagement also induces substantial conformational changes in MBV GP, probably facilitating membrane fusion. Furthermore, MBV GP is susceptible to the neutralizing nanobody, which mimics NPC1 at the receptor-binding site. Together, our findings reveal MBV GP as a highly efficient entry mediator and suggest structural mechanisms that may contribute to its enhanced entry efficiency.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ye et al. (2026) studied this question.

synapsesocial.com/papers/69b4fc7fb39f7826a300d6dehttps://doi.org/10.1038/s41586-026-10240-0
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants2024 · 6 citations
  2. 2Cryo-EM structure of Sudan ebolavirus glycoprotein complexed with its human endosomal receptor NPC12025 · 6 citations
  3. 3Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses2024 · 23 citations
  4. 4Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection2005 · 841 citations
  5. 5LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery2011 · 6,666 citations